Japan moves to regain prominence in Biotech

28-01-2014 Genetic Engineering NewsComments (0)


Japanese companies are also looking north of the border for deals: Also in 2013, Mitsubishi Tanabe Pharma acquired Canadian-based vaccine developer Medicago for C$357 million (about $322 million). “You have a lot of mid-sized pharmas in Japan.

Read more on Genetic Engineering News

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top